PATENT CLAIM ANALYSIS

Application Number: 15920654
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["540", "594000"]

Abstract:
The invention generally relates to adenylyl cyclase inhibitor compounds and methods for treating neuropathic or inflammatory pain by using those compounds.

Claim (Index 31):
A method of treating neuropathic or inflammatory pain, wherein the method comprising administering a pharmaceutical composition comprising a compound selected from the group consisting of: and any pharmaceutically acceptable salt or carrier thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.04762
- Patent Class: 540.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15044660', '13141199', '11018019', '11733606', '12054083']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6071878981973038
- 35 USC 102 Novelty (BERT): 0.5310474965824544
- Combined Prediction Score: 0.5995738580358189
- Mean Citation Score: 216.056394
- Max Citation Score: 317.5019200000001
- Similarity Product: 221.3826069498253

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test